Angeliki Kapellou

Dr. Angeliki Kapellou

Life Sciences, Metropolitan College, Athens, Attikí, Greece

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2023 in Nutrition Reviews
Verified
Journal Article
Closed access
AKAngeliki Kapellou
Angeliki Kapellou
AKAlexandra King
Alexandra King
CGCat Anna-Marie Graham
Cat Anna-Marie Graham
LPLeta Pilic
Leta Pilic
YMYiannis Mavrommatis
Yiannis Mavrommatis
Context: Although the stimulant and anxiogenic properties of caffeine are widely accepted, research on its specific effects on the brain remains controversial. Growing evidence shows that interindividual differences in caffeine response may be partly due to variations in genes such as CYP1A2 and ADORA2A, which have been used to identify individuals as “fast” or “slow” caffeine metabolizers and as having a “high” or “low” caffeine sensitivity, respectively. Objective: The objective of this review was to identify, evaluate, and discuss current evidence on the associations between common genetic variants, caffeine consumption, and brain-related outcomes in humans. Data Sources: PubMed and Embase databases were searched for relevant reports based on a predetermined search strategy. Data Extraction: Reports of observational and experimental studies on healthy adults who underwent (a) genetic analysis for polymorphisms in genes associated with caffeine metabolism and effects and (b) measurements of brain-related effects such as anxiety, insomnia, and cognitive performance associated with the consumption of caffeine (habitual intake or supplementation) were included. Data Analysis: Of the 22 records included, 15 were randomized controlled trials, 6 were cross-sectional studies, and 1 was a genome-wide association study. The main outcomes identified were cognitive performance (n = 9), anxiety (n = 7), and sleep disturbance/insomnia (n = 6). Polymorphisms in the CYP1A2 gene were associated with cognitive function, while variations in the ADORA2A gene were associated with anxiety and sleep disturbance. Conclusion: The present review has provided evidence that variability in the CYP1A2 and the ADORA2A genes may modulate the association between caffeine and brain-related outcomes. Future studies are warranted to investigate the specific polymorphisms implicated in each brain outcome, which cognitive functions are particularly related to caffeine (simple vs complex), whether there are gender differences in anxiety effects, and how habitual caffeine intake may influence the acute effects of caffeine. Systematic review registration: PROSPERO registration no. CRD42021257556.

14 May 2025 in Genes
Verified
Journal Article
Open access
PDF file
AKAngeliki Kapellou
Angeliki Kapellou
ESEffie Salata
Effie Salata
DVDimitrios-Miltiadis Vrachnos
Dimitrios-Miltiadis Vrachnos
Sevastiani PapailiaSevastiani Papailia
Sevastiani Papailia
Spiros VittasSpiros Vittas
Spiros Vittas
Type 2 diabetes mellitus (T2DM) remaina significant global health challenge, with its increasing prevalence and associated complications contributing to high morbidity and economic burden. Genetic factors play a crucial role in T2DM susceptibility, yet individual responses to dietary interventions vary widely, emphasizing the importance of gene–diet (G × D) interactions. This review synthesizes the current literature on the genetic basis of T2DM and the role of G × D interactions in shaping individual responses to diet. We examine the genetics implication in T2DM risk and modulation by dietary factors, with a focus on the potential of Nutrigenetics in guiding personalized nutrition (PN) strategies. Moreover, the clinical implications of these interactions for the personalized prevention and management of T2DM are explored, highlighting the promise of tailoring dietary recommendations based on genetic profiles. Critical research gaps, including the need for diverse and longitudinal studies, the integration of multi-omic data, and the inclusion of digital health technologies in PN are discussed. Finally, future directions for the field are outlined, advocating for more inclusive, large-scale studies to optimize PN approaches for diverse populations and improve the efficacy of T2DM prevention and management. This review underscores the potential of an individualized, genetically informed dietary approach in modulating the global burden of T2DM.

8 December 2024 in Journal of Psychopharmacology
Verified
Journal Article
Open access
AKAngeliki Kapellou
Angeliki Kapellou
LPLeta Pilic
Leta Pilic
YMYiannis Mavrommatis
Yiannis Mavrommatis
Background: Research on caffeine and cognitive performance remains controversial. Variations in genes associated with caffeine metabolism and response such as CYP1A2, AHR and ADORA2A may account for variable findings. Aim: To investigate caffeine × gene interactions on cognitive performance in all key domains of cognition in healthy individuals. Methods: Participants completed a lifestyle and food frequency questionnaire and a cognitive test battery including validated tasks to assess the domains of social cognition, memory, attention and executive function. Genotyping was performed for AHR rs6968554, CYP1A2 rs2472297, ADORA2A rs5751876, ADA rs73598374 and APOE rs429358 and rs7412. Results: Significant gene × caffeine interactions were observed for the domains of social cognition, ( F2, 123 = 5.848, p = 0.004) and executive function ( F2, 109 = 3.690, p = 0.028). ‘Slow’ metabolisers had a higher performance in social cognition compared with ‘fast’ metabolisers among high-caffeine consumers ( p = 0.004), while ‘fast’ metabolisers had a higher performance in executive function compared with ‘slow’ metabolisers among moderate caffeine consumers ( p = 0.002). Conclusions: The present findings suggest an association between genetic caffeine metabolism, habitual caffeine intake and cognitive function in the domains of social cognition and executive function. More research in naturalistic environments using larger cohorts is needed to confirm these findings to add to our understanding of how habitual caffeine may influence cognitive function based on individual genotype.

22 June 2021 in Nutrition and Health
Verified
Journal Article
Open access
PDF file
AKAngeliki Kapellou
Angeliki Kapellou
GSGabriela Silva
Gabriela Silva
LPLeta Pilic
Leta Pilic
YMYiannis Mavrommatis
Yiannis Mavrommatis
Background: Severe obesity (body mass index ≥ 40 kg/m2) and non-communicable diseases, both influenced by diet, have been associated with COVID-19. Genotype-based personalised nutrition advice may improve nutrition knowledge and enhance behaviour change towards better diet quality compared with conventional recommendations. Aim: To investigate the nutrition knowledge, food choices and diet quality in genotyped and non-genotyped individuals during the COVID-19 pandemic. Methods: One hundred and twenty-three healthy UK adults were recruited using convenience sampling through social networks. The online questionnaire consisted of the General Nutrition Knowledge Questionnaire, the Food Choices Questionnaire, and the EPIC-Norfolk Food Frequency Questionnaire (FFQ). FFQ was used to calculate participant diet quality with the Diet Quality Index-International and socio-demographic and anthropometric data. Results: Median general nutrition knowledge, diet variety and diet balance scores were higher in genotyped compared with non-genotyped individuals (71.0 ± 11.0 vs. 61.0 ± 15.0, p = <.001, 18.00 ± 5.00 vs. 15.00 ± 5.00, p = .007 and 2.00 ± 4.00 vs. 0.00 ± 2.00, p = .025, respectively). Pooled sample multiple regression showed that health motive positively influenced while familiarity motive negatively influenced diet quality index scores ( β = .428, t = 4.822, p = <.001 and β = –.356, t = –4.021, p = .001, respectively). Conclusions: Nutrition knowledge and diet quality indices of balance and variety were higher among genotyped compared with non-genotyped individuals; overall diet quality was similar between groups. This may be due to pandemic-specific factors, such as altered motives of food choice and availability.

22 July 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
AKAngeliki Kapellou
Angeliki Kapellou
TFThanos Fotis
Thanos Fotis
DVDimitrios-Miltiadis Vrachnos
Dimitrios-Miltiadis Vrachnos
ESEffie Salata
Effie Salata
ENEleni Ntoumou
Eleni Ntoumou
Spiros VittasSpiros Vittas
Spiros Vittas
Background/Objectives: Obesity, a major risk factor for cardiometabolic traits, is influenced by both genetic and environmental factors. Genetic studies have identified multiple single-nucleotide polymorphisms (SNPs) associated with obesity and related traits. This study aimed to examine the association between genetic risk score (GRS) and obesity-associated traits, while incorporating SNPs with established gene–diet interactions to explore their potential role in precision nutrition (PN) strategies. Methods: A total of 4279 participants were stratified into low- and intermediate-/high-GRS groups based on 18 SNPs linked to obesity and cardiometabolic traits. This study followed a case–control design, where cases included individuals with overweight/obesity, T2DM-positive (+), or CVD-positive (+) individuals and controls, which comprised individuals free of these traits. Logistic regression area under the curve (AUC) models were used to assess the predictive power of the GRS and traditional risk factors on BMI, T2DM and CVD. Results: Individuals in the intermediate-/high-GRS group had higher odds of being overweight or obese (OR = 1.23, CI: 1.03–1.48, p = 0.02), presenting as T2DM+ (OR = 1.56, CI: 1.03–2.49, p = 0.03) and exhibiting CVD-related traits (OR = 1.56, CI: 1.25–1.95, p < 0.0001), compared to the low-GRS group. The GRS was the second most predictive factor after age for BMI (AUC = 0.515; 95% CI: 0.462–0.538). The GRS also demonstrated a predictive power of 0.528 (95% CI: 0.508–0.564) for CVD and 0.548 (95% CI: 0.440–0.605) for T2DM. Conclusions: This study supports the potential utility of the GRS in assessing obesity and cardiometabolic risk, while emphasizing the potential of PN approaches in modulating genetic susceptibility. Incorporating gene–diet interactions provides actionable insights for personalized dietary strategies. Future research should integrate multiple gene–diet and gene–gene interactions to enhance risk prediction and targeted interventions.

26 July 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
AKAngeliki Kapellou
Angeliki Kapellou
Sevastiani PapailiaSevastiani Papailia
Sevastiani Papailia
TFThanos Fotis
Thanos Fotis
DVDimitrios-Miltiadis Vrachnos
Dimitrios-Miltiadis Vrachnos
DPDimitrios Papageorgiou
Dimitrios Papageorgiou
Spiros VittasSpiros Vittas
Spiros Vittas
Background/Objectives: Type 2 diabetes (T2D) is a multifactorial disorder arising from complex interactions between genetic susceptibility and environmental exposures, including diet. This systematic review aimed to synthesize and critically evaluate evidence on gene–diet interactions in T2D-related phenotypes among adults without diagnosed T2D at baseline. Methods: The review was conducted according to PRISMA guidelines and registered in PROSPERO (CRD420251175793). PubMed and Embase were systematically searched for eligible studies published up to November 2025. Observational studies and intervention trials examining interactions between dietary exposures and genetic variants, haplotypes, or genetic risk scores (GRSs) in relation to incident T2D, insulin resistance, glycemic traits, or β-cell function were included. Risk of bias was assessed using study design-specific tools. Results: A total of 61 reports representing 27 unique studies met the eligibility criteria, comprising 30 reports of randomized trials and 31 reports of non-randomized studies. Across studies, 55 Single Nucleotide Polymorphisms (SNPs) in 40 genes were examined, while 11 studies evaluated GRSs. The most frequently studied loci included TCF7L2, ADIPOQ, FTO, IRS1, GIPR and PPM1K. Reported interactions involved dietary patterns, macronutrient composition, dietary fat quality, fiber/whole-grain intake and specific foods, influencing incident T2D, insulin-related traits and glycemic outcomes. However, findings were heterogeneous, frequently inconsistent, and often lacked independent replication. Most randomized and non-randomized studies were judged at high or serious risk of bias. Conclusions: Genetic variation may contribute to interindividual differences in metabolic responses to diet, although robust and reproducible gene–diet interactions remain limited. Larger, well-powered, standardized studies across diverse populations are needed to establish clinically meaningful applications of Precision Nutrition (PN) in T2D prevention.